Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Takeda Pharmaceutical Company Limited company logo
Takeda Pharmaceutical Company Limited logo

Takeda Pharmaceutical Company Limited (TAK)

Profile

Company profile for Takeda Pharmaceutical Company Limited (TAK)
MetricValue
Full NameTakeda Pharmaceutical Company Limited
TickerNYSE: TAK
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryJapan
IPO
IndexesNot included
Websitetakeda.com
Employees47,455

Key Metrics

Takeda Pharmaceutical Company Limited Key Details
MetricDateValue
Price$15.62
Price, 1D Change+0.19%
Market Cap$49B
TTM Dividend Yield4.23%
PE Ratio198.22
Beta0.22
Revenue$30B
Revenue, 1Y Change+1.92%
EPS$0.22
EPS, 1Y Change-30.04%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Takeda Pharmaceutical Company Limited chart

Events

Takeda Pharmaceutical Company Limited Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.32
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeTKPYY
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TAK Estimates
MetricDateValue
EPS$0.22
EPS EstimateN/A$73.97
EPS Est. ChangeN/A+33,446.03%
Revenue$30.05B
Revenue EstimateN/A$4,510.20B
Revenue Est. ChangeN/A+14,907.63%
Current Price$15.62
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

TAK EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$0.34$0.32-7.29%
-$0.22-
$73.97N/A+33,446.03%
$122.17N/A+55,306.35%
TAK EPS reported versus estimate values chart

Revenue

TAK revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$26.65M$29.49B+110,542.13%
$4,611.64B$30.05B-99.35%
$4,510.20BN/A+14,907.63%
$4,532.75BN/A+14,982.64%
TAK revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TAK Performance
MetricDateValue
Price, 1Y+17.89%
Price, 3Y+0.13%
Market Cap, 1Y+17.44%
Market Cap, 3Y+1.71%
Revenue, 1Y+1.92%
Revenue, 3Y-5.38%
EPS, 1Y-30.04%
EPS, 3Y-66.02%

🔒 Log In To Unlock Full Data

Technical Indicators

TAK Technical Indicators
MetricDateValue
Current Price$15.62
SMA 200$14.66
SMA 200 vs Price-6.12%
SMA 50$14.37
SMA 50 vs Price-8.03%
Beta0.22
ATR$0.19
14-Day RSI73.73
10-Day Volatility16.73%
1-Year Volatility20.56%

Dividends

TAK Dividends
MetricDateValue
Last Paid$0.32
UpcomingN/AN/A
Dividend Yield4.26%
Total Dividend$0.67
Dividends Paid$1.98B
Payout Ratio279.72%

🔒 Log In To Unlock Full Data

Income & Profitability

TAK Income & Profitability
MetricDateValue
Revenue$30.05B
EPS$0.22
Gross Profit$16.10B
Gross Margin53.59%
Operating Profit$4.12B
Operating Margin-32.71%
Net Income$709.37M
Net Margin2.36%
EBITDA$9.11B

🔒 Log In To Unlock Full Data

Financial Health

TAK Financial Health
MetricDateValue
Debt To Equity0.73
Current Ratio1.01
Quick Ratio0.52
-
F-Score8
Altman Z-Score1.18

Valuations

TAK Valuations
MetricDateValue
PE Ratio198.22
PS Ratio1.67
PB Ratio1.02
EV/EBITDA9.07
Enterprise ValueN/A-

Balance Sheet

TAK Balance Sheet
MetricDateValue
Book Value$46.38B
Cash & Equivalents$2.58B
Total Assets$95.28B
Current Assets$16.86B
Total Liabilities$48.90B
Current Liabilities$16.76B
Total Debt$34.03B
Short Term Debt$4.10B
Accounts Payable$2.06B

Expenses

TAK Expenses
MetricDateValue
Total Expenses$29.34B
Operating Expenses$11.99B
Cost Of Goods Sold$13.95B
SG&A$7.25B
D&A$4.99B
Interest Expense$0.00
Income Tax$439.10M

Cash Flow

TAK Cash Flow
MetricDateValue
CFO$6.31B
CFI-$2.53B
CFF-$4.19B
Capex$2.28B
Free Cash Flow$4.03B

Recent analyst updates

TAK Recent analyst updates
MetricDateValue
TD Cowen→
TD Cowen
B of A Securities→
Cowen & Co.→
Morgan Stanley→
JP Morgan
Cowen & Co.
Jefferies

Analyst sentiment

Sentiment over the past month
TAK analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TAK institutional ownership distribution chart

Screeners with TAK

Data Sources & References

  1. TAK Official Website www.takeda.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
  3. TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
  4. TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak

FAQ

  • What is the ticker symbol for Takeda Pharmaceutical Company Limited?

    The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK

  • Does Takeda Pharmaceutical Company Limited pay dividends?

    Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.32, with an ex-dividend date on September 30, 2025

  • What sector is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Healthcare sector

  • What industry is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Specialty & Generic Drug Manufacturers industry

  • What country is Takeda Pharmaceutical Company Limited based in?

    Takeda Pharmaceutical Company Limited is headquartered in Japan

  • When did Takeda Pharmaceutical Company Limited go public?

    Takeda Pharmaceutical Company Limited initial public offering (IPO) was on January 5, 2010

  • Is Takeda Pharmaceutical Company Limited in the S&P 500?

    No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index

  • Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?

    No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index

  • Is Takeda Pharmaceutical Company Limited in the Dow Jones?

    No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index

  • When was Takeda Pharmaceutical Company Limited last earnings report?

    Takeda Pharmaceutical Company Limited's most recent earnings report was on October 30, 2025

  • When does Takeda Pharmaceutical Company Limited report earnings?

    The next expected earnings date for Takeda Pharmaceutical Company Limited is January 29, 2026